IE
MYOK

Israel Englander’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Israel Englander’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-35,000
Closed -$1.71M – 4349
2018
Q1 		$1.71M Buy
+35,000
New +$1.82M ﹤0.01% 2409

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Israel Englander's MYOK Position: Q3 2020 in Review

Israel Englander sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 102,900 shares — an estimated $9.94M sold.

Israel Englander first reported a position in MYOK in Q1 2016 and held it in 14 quarters. The position peaked at $23.7M in Q2 2018. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Israel Englander reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Israel Englander sold 102,900 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $9.94M.
  • Israel Englander first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 14 quarters.
  • Israel Englander's MyoKardia, Inc. Common Stock position peaked at $23.7M in Q2 2018.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.